Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retrotransposon Gag-like protein 8B (RTL8B) is a small, eutherian-specific protein encoded by the RTL8B gene, which is clustered on the X chromosome alongside RTL8A and RTL8C. These proteins are derived from endogenous retroviral sequences and share high homology. RTL8B is expressed in both the nucleus and cytoplasm of neurons, with evidence for nucleolar localization and involvement in subnuclear protein quality control condensates, particularly by interacting with the ubiquitin receptor UBQLN2. In mouse models, deletion of Rtl8a and Rtl8b leads to neuropsychiatric-like behaviors, late-onset obesity, and reduced social response, recapitulating symptoms seen in human Prader–Willi syndrome and suggesting a role in neural gene regulation or maintenance. While its exact molecular function remains under investigation, RTL8B is implicated in the regulation of UBQLN2 nuclear translocation during cellular stress and is associated with certain neurodevelopmental and neurodegenerative diseases through expression or processing changes, but it is not established as a direct therapeutic target and has no current drug interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retrotransposon Gag-like protein 8B (RTL8B).